Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort

被引：4
|
作者：
Owen, S. A. [1 ]
Lunt, M. [1 ]
Hider, S. L. [2 ]
Bruce, I. N. [1 ]
Barton, A. [1 ]
Thomson, W. [1 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Keele Univ, Keele, Staffs, England
来源：
ARTHRITIS AND RHEUMATISM | 2010年 / 62卷 / 12期
关键词：
POLYMORPHISMS; FOLATE; GENE;
D O I：
10.1002/art.27754
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3827 / 3829
页数：3
相关论文
共 50 条
  • [1] A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recenvonset rheumatoid arthritis.
    Wessels, Judith A. M.
    van der Kooij, Sjoerd M.
    Le Cessie, Saskia
    Allaart, Cornelia F.
    de Vries-Bouwstra, Jeska
    Goekoop-Ruiterman, Yvonne P. M.
    de Jonge, Robert
    van der Straaten, Tahar
    Huizinga, Tom W. J.
    Guchelaar, Henk-Jan
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4048 - 4049
  • [2] A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis
    Wessels, Judith A. M.
    van der Kooij, Sjoerd M.
    le Cessie, Saskia
    Kievit, Wietske
    Barerra, Pilar
    Allaart, Cornelia F.
    Huizinga, Tom W. J.
    Guchelaar, Henk-Jan
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1765 - 1775
  • [3] Pharmacogenetic aspects of methotrexate in a cohort of Colombian patients with rheumatoid arthritis
    Londono, John
    Saldarriaga, Eugenia-Lucia
    Rueda, Juan C.
    Giraldo-Bustos, Rodrigo
    Angarita, Jose-Ignacio
    Restrepo, Luisa
    Ballesteros-Munoz, Jesus
    Gonzalez, Camilo
    Ospina, Maria J.
    Arias-Correal, Sofia
    Reyes-Martinez, Viviana
    Bernalmacias, Santiago
    Villota-Eraso, Catalina
    Santos-Moreno, Pedro
    Martinez-Rodriguez, Nancy
    Santos, Ana M.
    [J]. BIOMEDICAL REPORTS, 2020, 13 (04) : 1 - 7
  • [4] Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study
    Meltem Alkan Melikoglu
    Eda Balkan
    [J]. Inflammopharmacology, 2022, 30 : 193 - 197
  • [5] Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study
    Melikoglu, Meltem Alkan
    Balkan, Eda
    [J]. INFLAMMOPHARMACOLOGY, 2022, 30 (01) : 193 - 197
  • [6] Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis
    Qiu, Qi
    Huang, Jing
    Lin, Yang
    Shu, Xiaoming
    Fan, Huizheng
    Tu, Zhihua
    Zhou, Youwen
    Xiao, Cheng
    [J]. MEDICINE, 2017, 96 (11)
  • [7] Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients
    Eektimmerman, Frank
    Allaart, Cornelia F.
    Hazes, Johanna M. W.
    den Broeder, Alfons A.
    Fransen, Jaap
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    [J]. PHARMACOGENOMICS, 2019, 20 (02) : 85 - 93
  • [8] The efficacy and toxicity of methotrexate combination vs. monotherapy in rheumatoid arthritis: An updated systematic review and metaanalysis
    Katchamart, Wanruchada
    Bombardier, Claire
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1198 - 1198
  • [9] Clinical efficacy of combination therapy of prospidin and methotrexate vs monotherapy of methotrexate for rheumatoid arthritis
    Nemtsov, BF
    Simonova, OV
    Politova, NN
    Benenson, EV
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 168 - 168
  • [10] Pharmacogenetic Polymorphisms Contributing to Toxicity Induced by Methotrexate in the Southern Spanish Population with Rheumatoid Arthritis
    Cristian Plaza-Plaza, Jose
    Aguilera, Margarita
    Canadas-Garre, Marisa
    Chemello, Clarice
    Gonzalez-Utrilla, Alfonso
    Faus Dader, Maria Jose
    Angel Calleja, Miguel
    [J]. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2012, 16 (11) : 589 - 595
12345